Moolec Science SA
Moolec is a food-tech and life sciences company developing alternative proteins and ingredients through molecular farming and precision fermentation. Its molecular farming programs include Piggy Sooy, which expresses porcine proteins in soybeans, and GLASO, which produces GLA oil from safflower. Its SynBio Powerlabs facility in Finland develops precision fermentation and scale-up services, while Mycofood is a fungal protein ingredient. Moolec also operates ValoraSoy, which makes and sells texturized soy ingredients for food applications, and Agrality, which provides field trials, regulatory testing, crop analysis and seed production. InMet offers synthetic biology and pilot-scale fermentation capabilities. Moolec earns money from services and fermentation contracts, and from selling ValoraSoy’s soy ingredients; it is also developing commercial channels for fermentation-derived ingredients and molecular farming products. Its operations span the United States, Europe and South America. Moolec is based at c/o Ogier Global (Cayman), 89 Nexus Way, Camana Bay, Grand Cayman KY1-9009.
No SEC Form 4 filings for $MLEC in the last 30 days.
See all $MLEC insider activity →Moolec Science (MLEC) shareholders approved voluntary liquidation. Nasdaq will delist its shares, effective November 3, 2026, due to the winding-up and public interest considerations.
Moolec Science (NASDAQ: MLEC) has announced a 15-for-1 share consolidation, effective January 5, 2026, aimed at regaining compliance with Nasdaq's minimum bid price rule. This consolidation will reduce the number of issued and outstanding shares from 10,891,761 to approximately 726,118 and change the par value from US$0.10 to US$1.50 per share. The company's stock experienced a 4.18% decline following the announcement, reflecting a moderate negative market reaction.
Moolec Science SA (NASDAQ:MLEC) announced a 15-for-1 share consolidation effective January 5, 2026, to regain compliance with Nasdaq's minimum bid price requirement. This consolidation will reduce outstanding shares and increase the par value per share; however, the company's market capitalization remains small. The food ingredient company, which focuses on producing animal proteins in plants, has seen its stock price fall significantly over the past year.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning MLEC (Moolec Science SA). Coverage has skewed bearish: 0 bullish, 0 neutral, and 2 bearish.
Recent MLEC coverage spans financial news and corporate actions.
Delisting risk is now concrete, likely driving liquidity compression and forced positioning changes for holders and traders.
Moolec Science's 15-for-1 share consolidation aims to regain Nasdaq compliance, leading to a moderate negative market reaction as indicated by a 4.18% stock decline and somewhat-bearish sentiment.
The 15-for-1 share consolidation is a strategic move to regain compliance with Nasdaq's minimum bid price requirement. Despite this, the company's market capitalization remains small, and its stock has experienced significant decline over the past year.
Moolec Science's planned share consolidation aims to improve stock price stability and compliance with Nasdaq requirements. However, the negative analyst sentiment and bearish technical signals suggest limited short-term upside.
The adjournment due to lack of quorum suggests potential corporate governance issues or shareholder engagement challenges, which could influence investor sentiment and stock performance.
AlphAI scores every news story that mentions MLEC with an AI model for sentiment and relevance, and aggregates insider trades from Moolec Science SA's SEC EDGAR Form 4 filings. Figures refresh continuously.
Moolec Science (MLEC) shareholders approved voluntary liquidation. Nasdaq will delist its shares, effective November 3, 2026, due to the winding-up and public interest considerations.
3 min readMoolec Science (NASDAQ: MLEC) has announced a 15-for-1 share consolidation, effective January 5, 2026, aimed at regaining compliance with Nasdaq's minimum bid price rule. This consolidation will reduce the number of issued and outstanding shares from 10,891,761 to approximately 726,118 and change the par value from US$0.10 to US$1.50 per share. The company's stock experienced a 4.18% decline following the announcement, reflecting a moderate negative market reaction.
2 min readMoolec Science SA (NASDAQ:MLEC) announced a 15-for-1 share consolidation effective January 5, 2026, to regain compliance with Nasdaq's minimum bid price requirement. This consolidation will reduce outstanding shares and increase the par value per share; however, the company's market capitalization remains small. The food ingredient company, which focuses on producing animal proteins in plants, has seen its stock price fall significantly over the past year.
2 min readMoolec Science (MLEC) announced a 15-for-1 share consolidation effective January 5, 2026, aiming to reduce outstanding shares from 10,891,761 to approximately 726,118. This move is intended to help the company regain compliance with Nasdaq's minimum bid price requirement. TipRanks' AI Analyst, Spark, rated MLEC as "Underperform" due to financial challenges despite revenue growth, bearish technical analysis, and unfavorable valuation.
3 min readMoolec Science SA (NASDAQ:MLEC) announced the adjournment of its virtual extraordinary general meeting of shareholders to December 16, 2025, due to a lack of the required quorum. Only 39.85% of eligible shares were voted, falling short of the necessary threshold. The company stated that if a quorum isn't met at the rescheduled meeting, any present shareholders or proxies will constitute a quorum to proceed with the agenda.
2 min readThe most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.
4 min read
